६ मंसिर, काठमाडौं । काठमाडौंको दरबारमार्गमा नेपाल-जापान महोत्सव-२०२६ जारी छ। नेपाल-जापानबीच कूटनीतिक सम्बन्ध स्थापना भएको ...
४ मंसिर, काठमाडौं । नेपाली कांग्रेसका सभापति गगन थापाले निर्वाचनको निष्पक्षता सुनिश्चित गर्ने ठूलो जिम्मेवारी सरकारको रहेको ...
As the title-chasers prepare for Maurice Steijn’s return, key reinforcements rejoin the squad while a lingering question mark remains over Julian Brandt’s fitness for Sunday’s Eredivisie clash. The ...
Open Task Manager on a Windows 11 PC, and it's easy to panic no matter how much RAM you have. Even without many apps open, your computer will likely be using more than 50% of its memory. And while ...
Google's crawler now strictly enforces standard JSON formatting when reading your site's structured data, schema markup, instead of auto-correcting double-escaped HTML text. "To bring our parser up to ...
We're so connected to our smartphones nowadays that even when they're charging, we feel the need to use them. I have a charging cable beside my living room couch so I can fuel my phone while I scroll ...
As enterprise AI systems scale to handle complex workflows, practitioners face the challenge of routing subtasks to the right tools and skills. Agents can have hundreds of tools and skills and get ...
Ajax Therapeutics is among about 10 publicly-announced acquisitions by Eli Lilly so far this year. (Angus Liu/Fierce Pharma) Eli Lilly’s up-to-$2.3 billion acquisition of Ajax Therapeutics is facing ...
It’s been three-and-a-half years since generative AI exploded onto the scene. In this past year, progress has continued its relentless pace: Vibe coding took off, companies embraced agentic workflows, ...
Eli Lilly LLY-0.73%decrease; down pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...
April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results